OrbiMed Israel GP Ltd.

Insider Reports History

Entity
Company
Location
89 Medinat Hayehudim Street, 11 Th Floor, Herzliya, Israel
Signature
OrbiMed Israel BioFund GP Limited, /s/ Douglas Coon, Chief Compliance Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by OrbiMed Israel GP Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Chemomab Therapeutics Ltd. 10%+ Owner American Depository Shares 2.24M $10.1M $4.51 Jan 3, 2023 Indirect
9 METERS BIOPHARMA, INC. 10%+ Owner Common Stock 8.57M $1.95M $0.23 Jun 25, 2021 Indirect

Insider Reports Filed by OrbiMed Israel GP Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMMB Chemomab Therapeutics Ltd. Jan 3, 2023 2 -$1.21M 4 Jan 5, 2023 10%+ Owner
NMTR 9 METERS BIOPHARMA, INC. Jun 23, 2021 3 -$20.9M 4 Jun 25, 2021 10%+ Owner
NMTR 9 METERS BIOPHARMA, INC. May 11, 2021 4 $20.8K 4 May 13, 2021 10%+ Owner